Distribuição geográfica da leishmaniose tegumentar americana no Estado do Espírito Santo - Brasil

Com base nos registros de 730 pacientes portadores de Leishmaniose Tegumentar Americana (LTA) referentes ao período de janeiro de 1972 a dezembro de 1982, os autores realizaram um estudo da distribuição geográfica dessa parasitose no Estado do Espírito Santo. Os pacientes procediam de 36 dos 53 municípios que compõem o Estado, destacando-se Viana e Cariacica como os de maior prevalência, somando juntos 442 casos (60,54%), com 259 destes residindo numas poucas localidades, contínuas entre si, formando uma área endêmica, com transmissão ocorrendo provavelmente no peri e intra-domicílio. Esta área de alta endemicidade, pertencente principalmente ao vale do rio Formate, estende-se também ao município de Domingos Martins através da localidade de Biriricas. Nos demais municípios a LTA caracterizou- se como uma doença profissional de ocorrência antiga no Estado.

Titrimetric and spectrophotometric assay of bupropion hydrochloride in pharmaceuticals using mercury(II) nitrate

Two simple, rapid and accurate methods for the determination of bupropion hydrochloride (BUP) in pure and in pharmaceutical preparations are described. Both methods are based on the measurement of the chloride of its hydrochloride. In the titrimetric method, the chloride content of bupropion hydrochloride is determined by titrating with mercury(II)nitrate using diphenylcarbazone-bromophenol blue as indicator. Titrimetric method is applicable over a range 2-20 mg of BUP and the reaction stoichiometry is found to be 2:1 (BUP: Hg(NO3)2). The spectrophotometric method involves the addition of a measured excess of mercury(II) nitrate reagent in formate buffer to the drug, and after ensuring the reaction had gone to completion, the unreacted mercury(II) is treated with a fixed amount of diphenylcarbazone, and absorbance measured at 515 nm. The absorbance is found to decrease linearly with increasing concentration of BUP and the calibration curve is linear over 1.0-15.0 µg mL-1 BUP. The proposed methods were successfully applied to the determination of BUP in commercially available dosage forms with good accuracy and precision, and without detectable interference by excipients. The accuracy was further ascertained by placebo blank and synthetic mixture analyses and also by recovery experiments via standard-addition procedure.